$41.15
0.56[1.38%]
Last update: 1:06PM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/31/2024 | GSK | GSK | FY | 2024 | $1.64 | $1.69 | $4.05 | $39.53B | $40.29B | $39.82B | Get Alert |
11/01/2023 | GSK | GSK | FY | 2023 | $2.07 | $2.12 | $3.86 | $41.58B | $41.95B | $35.50B | Get Alert |
07/26/2023 | GSK | GSK | FY | 2023 | $1.99 | $2.05 | $3.80 | $39.63B | $40.37B | $37.43B | Get Alert |
04/26/2023 | GSK | GSK | FY | 2023 | $1.90 | $1.96 | $3.68 | $37.75B | $38.47B | $35.72B | Get Alert |
02/01/2023 | GSK | GSK | FY | 2023 | $1.94 | $1.99 | $3.64 | $38.54B | $39.27B | $35.92B | Get Alert |
11/02/2022 | GSK | GSK | FY | 2022 | — | — | — | $50.67B | $51.60B | $32.29B | Get Alert |
07/27/2022 | GSK | GSK | FY | 2022 | — | — | — | $49.73B | $50.67B | $38.72B | Get Alert |
10/27/2021 | GSK | GlaxoSmithKline | FY | 2021 | $1.56 | $1.59 | $2.86 | — | — | — | Get Alert |
07/29/2020 | GSK | GSK | FY | 2020 | $1.56 | $1.60 | $2.99 | — | — | — | Get Alert |
02/05/2020 | GSK | GSK | FY | 2020 | $1.56 | $1.60 | $3.06 | — | — | — | Get Alert |
07/24/2019 | GSK | GSK | FY | 2019 | $1.42 | $1.45 | $2.88 | — | — | — | Get Alert |
The last reported Earnings numbers were from January 31, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $1.64 and $1.69 versus the estimated EPS of $4.05.
Browse guidance and forecast on all stocks.